Xencor | XNCR - Собственный капитал и резервы





Собственный капитал и резервы Изменить Дата
AbbVie USD -5.94B 721M 2026-06
Alnylam Pharmaceuticals USD 1.35B 278.74M 2026-06
Amgen USD 11.69B 2.5B 2026-06
Arrowhead Research USD 465.53M 148.45M 2026-06
AstraZeneca USD 50.3B 2.96B 2026-06
Biogen USD 18.85B 196.3M 2026-06
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Cytokinetics USD -173.49M 653.08M 2026-06
GlaxoSmithKline GBP 17.64B 223M 2026-06
J&J USD 84.97B 3.78B 2026-06
Karyopharm Therapeutics USD -265.65M 27.28M 2026-03
MacroGenics USD 42.87M 21.68M 2026-06
Merck USD 41.93B 3.94B 2026-06
Novartis USD 41.95B 3.02B 2026-06
Pfizer USD 85.19B 4.91B 2026-06
Regeneron Pharmaceuticals USD 31.71B 287.8M 2026-06
Roche Holding CHF 32.69B 1.11B 2026-06
Xencor USD 503.23M 12.4M 2026-06